Bob Hoffman | Association for Accessible Medicines
AAM All Access Podcast - Dan Leonard speaks with Mary Beth Powers, President and CEO of CMMB.

Bob Hoffman

Executive Vice President, US Generics, Lupin Pharmaceuticals, Inc.
Bob Hoffman
Bob Hoffman
Lupin Pharmaceuticals, Inc.

Bob Hoffman is the Executive Vice President of US Generics for Lupin Pharmaceuticals, Inc. In this role, he is responsible for executing the strategic direction of the business and all of the Commercial Operations functions.​

He has been with Lupin since 2005 and has over 31 years of experience in the pharmaceutical industry. Prior to launching Lupin’s generic business in the US, he held multiple managerial roles at companies such as Pliva Pharmaceuticals, Lek Pharmaceuticals, Takeda Pharmaceuticals, and Schein Pharmaceuticals.​

Bob has a Bachelor’s of Arts degree in Business Administration, with a concentration in Management and Marketing from Augustana College.​

Latest Tweets

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.